Senores Pharmaceuticals has informed that this is with reference to the Media Release submitted along with the Outcome of Board Meeting held on January 20, 2026 for approval of Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. Post submission of the Outcome, it has come to notice that inadvertently in Annexure B. Media Release, there was a minor typing error. Further, in order to set the records right for all the stakeholders, it enclosed a copy of revised Media Release as Annexure-A. Furthermore, since the Media Release forms the part of the Outcome of the Board Meeting held on January 20,2026 filed with the stock exchanges. The said Outcome shall always be read in conjunction with this Corrigendum.
The above information is a part of company’s filings submitted to BSE.
